دورية أكاديمية

Behavior of Iron and Ferritin After Bariatric Surgery in Patients With and Without Hepatic Steatosis.

التفاصيل البيبلوغرافية
العنوان: Behavior of Iron and Ferritin After Bariatric Surgery in Patients With and Without Hepatic Steatosis.
المؤلفون: da Costa Leite Junior G; Departamento de Ciências da Vida, Universidade do Estado da Bahia - UNEB, Rua Silveira Martins, 2555, Cabula, Salvador, BA, CEP: 41.150-000, Brazil., Lacerda MD; Faculdade de Tecnologia e Ciências - UNIFTC, Salvador, BA, Brazil., Alencar TALB; Faculdade de Tecnologia e Ciências - UNIFTC, Salvador, BA, Brazil., Café M; IMC Obesity Center, Hospital Aliança, Salvador, BA, Brazil., Giuffrida FMA; Departamento de Ciências da Vida, Universidade do Estado da Bahia - UNEB, Rua Silveira Martins, 2555, Cabula, Salvador, BA, CEP: 41.150-000, Brazil. fgiuffrida@uneb.br.
المصدر: Obesity surgery [Obes Surg] 2021 Nov; Vol. 31 (11), pp. 4761-4766. Date of Electronic Publication: 2021 Aug 03.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 9106714 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1708-0428 (Electronic) Linking ISSN: 09608923 NLM ISO Abbreviation: Obes Surg Subsets: MEDLINE
أسماء مطبوعة: Publication: 2006- : New York : Springer Science + Business Media
Original Publication: Oxford, OX, UK : Rapid Communications of Oxford, [1991-
مواضيع طبية MeSH: Bariatric Surgery* , Gastric Bypass* , Obesity, Morbid*/surgery, Ferritins ; Humans ; Iron
مستخلص: Background: Iron deficiency and hepatic steatosis are common in bariatric surgery patients. Steatosis can falsely elevate ferritin values even in presence of iron deficiency. This study aims to assess the influence of hepatic steatosis on iron deficiency and replacement therapy after bariatric surgery.
Methods: Seventy-nine individuals undergoing gastric bypass have been studied at 4 time points (preoperative and 1, 3, and 6 months after surgery). Weight, body mass index (BMI), iron, ferritin, vitamin B12, folate, hemoglobin, gamma-glutamyl transferase (GGT), alanine aminotransferase (ALT), aspartate aminotransferase (AST), and use of iron replacement were recorded.
Results: Forty-two individuals (53%) had moderate/severe steatosis assessed by ultrasound. No differences were seen in iron profile and replacement therapy features compared to individuals with no/mild steatosis both in the preoperative and postoperative periods. Mixed model analysis showed ferritin levels to be higher in the moderate/severe steatosis group than in no/mild steatosis at the 6th month (139 ± 131 vs. 60.9 ± 49.8, p < 0.05). Values in both groups were lower than baseline, with p < 0.0001. The same was observed with serum iron (92.1 ± 39.6 moderate/severe steatosis vs. 68.6 ± 33.4 no/mild steatosis, p < 0.001; p from baseline < 0.01 for both). GGT was higher in moderate/severe steatosis in the 3rd month (38.8 ± 40.5 vs. 28.8 ± 20.8, p < 0.05; p from baseline < 0.0001 for both).
Conclusions: Ferritin levels were consistently higher in individuals with steatosis in the follow-up of bariatric surgery, but no apparent implication on the diagnosis of iron deficiency and in the prescription of replacement therapy was demonstrated at 6 months of follow-up. Longer studies are probably necessary to investigate this matter.
(© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
References: Blüher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15:288–98. (PMID: 10.1038/s41574-019-0176-8)
Tremmel M, Gerdtham U-G, Nilsson PM, Saha S. Economic burden of obesity: a systematic literature review. Int J Environ Res Pu. 2017;14:435. (PMID: 10.3390/ijerph14040435)
O’Brien PE, Hindle A, Brennan L, Skinner S, Burton P, Smith A, et al. Long-term outcomes after bariatric surgery: a systematic review and meta-analysis of weight loss at 10 or more years for all bariatric procedures and a single-centre review of 20-year outcomes after adjustable gastric banding. Obes Surg. 2019;29:3–14. (PMID: 10.1007/s11695-018-3525-0)
Young MT, Gebhart A, Phelan MJ, Nguyen NT. Use and outcomes of laparoscopic sleeve gastrectomy vs laparoscopic gastric bypass: analysis of the American College of Surgeons NSQIP. J Am Coll Surgeons. 2015;220:880–5. (PMID: 10.1016/j.jamcollsurg.2015.01.059)
Borisenko O, Colpan Z, Dillemans B, Funch-Jensen P, Hedenbro J, Ahmed AR. Clinical indications, utilization, and funding of bariatric surgery in Europe. Obes Surg. 2015;25:1408–16. (PMID: 10.1007/s11695-014-1537-y)
Bal BS, Finelli FC, Shope TR, Koch TR. Nutritional deficiencies after bariatric surgery. Nat Rev Endocrinol. 2012;8:544–56. (PMID: 10.1038/nrendo.2012.48)
Barr J, Caballería J, Martínez-Arranz I, Domínguez-Díez A, Alonso C, Muntané J, et al. Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression. J Proteome Res. 2012;11:2521–32. (PMID: 10.1021/pr201223p)
Pontiroli AE, Benetti A, Folini L, Merlotti C, Frigè F. Other aspects of bariatric surgery: liver steatosis, ferritin and cholesterol metabolism. Nutr Hosp. 2013;28(Suppl 2):104–8. (PMID: 23834053)
Kheniser KG, Kashyap SR, Schauer PR, Lam ETC, Kullman ES. Prevalence of anemia in subjects randomized into roux-en-Y gastric bypass or sleeve gastrectomy. Obes Surg. 2017;27:1381–6. (PMID: 10.1007/s11695-017-2573-1)
Kowdley KV, Belt P, Wilson LA, Yeh MM, Neuschwander-Tetri BA, Chalasani N, et al. Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease. Hepatology. 2012;55:77–85. (PMID: 10.1002/hep.24706)
Jung JY, Shim J-J, Park SK, Ryoo J-H, Choi J-M, Oh I-H, et al. Serum ferritin level is associated with liver steatosis and fibrosis in Korean general population. Hepatol Int. 2019;13:222–33. (PMID: 10.1007/s12072-018-9892-8)
Krzizek E-C, Brix JM, Stöckl A, Parzer V, Ludvik B. Prevalence of Micronutrient Deficiency after Bariatric Surgery. Obes Facts. 2021;14:197–204. (PMID: 10.1159/000514847)
Steenackers N, der Schueren BV, Mertens A, Lannoo M, Grauwet T, Augustijns P, et al. Iron deficiency after bariatric surgery: what is the real problem? P Nutr Soc. 2018;77:445–55. (PMID: 10.1017/S0029665118000149)
Lewis C-A, de Jersey S, Seymour M, Hopkins G, Hickman I, Osland E. Iron, vitamin B12, folate and copper deficiency after bariatric surgery and the impact on anaemia: a systematic review. Obes Surg. 2020;30:4542–91. (PMID: 10.1007/s11695-020-04872-y)
Andrews NC. Forging a field: the golden age of iron biology. Blood. 2008;112:219–30. (PMID: 10.1182/blood-2007-12-077388)
Lynch S, Pfeiffer CM, Georgieff MK, Brittenham G, Fairweather-Tait S, Hurrell RF, et al. Biomarkers of nutrition for development (BOND)—iron review. J Nutrition. 2018;148:1001S-1067S. (PMID: 10.1093/jn/nxx036)
Shankar P, Boylan M, Sriram K. Micronutrient deficiencies after bariatric surgery. Nutrition. 2010;26:1031–7. (PMID: 10.1016/j.nut.2009.12.003)
Malinowski SS. Nutritional and metabolic complications of bariatric surgery. Am J Medical Sci. 2006;331:219–25. (PMID: 10.1097/00000441-200604000-00009)
Antoine D, Li Z, Quilliot D, Sirveaux M-A, Meyre D, Mangeon A, et al. Medium term post-bariatric surgery deficit of vitamin B12 is predicted by deficit at time of surgery. Clin Nutr. 2021;40:87–93. (PMID: 10.1016/j.clnu.2020.04.029)
Li Z, Gueant-Rodriguez R-M, Quilliot D, Sirveaux M-A, Meyre D, Gueant J-L, et al. Folate and vitamin B12 status is associated with insulin resistance and metabolic syndrome in morbid obesity. Clin Nutr. 2018;37:1700–6. (PMID: 10.1016/j.clnu.2017.07.008)
Guan B, Chen Y, Chong TH, Peng J, Mak TK, Wang C, et al. Effect of bariatric surgery on serum enzyme status in obese patients. Obes Surg. 2020;30:2700–7. (PMID: 10.1007/s11695-020-04554-9)
Burza MA, Romeo S, Kotronen A, Svensson P-A, Sjöholm K, Torgerson JS, et al. Long-term effect of bariatric surgery on liver enzymes in the Swedish Obese Subjects (SOS) study. Plos One. 2013;8:e60495. (PMID: 10.1371/journal.pone.0060495)
Ledoux S, Sami O, Calabrese D, Gall ML, Flamant M, Coupaye M. Gastric bypass specifically impairs liver parameters as compared with sleeve gastrectomy, independently of evolution of metabolic disorders. Surg Obes Relat Dis. 2019;15:220–6. (PMID: 10.1016/j.soard.2018.10.035)
Lassailly G, Caiazzo R, Ntandja-Wandji L-C, Gnemmi V, Baud G, Verkindt H, et al. Bariatric surgery provides long-term resolution of nonalcoholic steatohepatitis and regression of fibrosis. Gastroenterology. 2020;159:1290-1301.e5. (PMID: 10.1053/j.gastro.2020.06.006)
Wu J, You J, Yerian L, Shiba A, Schauer PR, Sessler DI. Prevalence of liver steatosis and fibrosis and the diagnostic accuracy of ultrasound in bariatric surgery patients. Obes Surg. 2012;22:240–7. (PMID: 10.1007/s11695-011-0509-8)
فهرسة مساهمة: Keywords: Anemia; Bariatric surgery; Ferritin; Iron; Obesity; Steatosis
المشرفين على المادة: 9007-73-2 (Ferritins)
E1UOL152H7 (Iron)
تواريخ الأحداث: Date Created: 20210803 Date Completed: 20211025 Latest Revision: 20211025
رمز التحديث: 20231215
DOI: 10.1007/s11695-021-05629-x
PMID: 34341911
قاعدة البيانات: MEDLINE
الوصف
تدمد:1708-0428
DOI:10.1007/s11695-021-05629-x